87572-56-3

Upstream product

• 13734-34-4 N-tert-butoxycarbonyl-L-phenylalanine 
• 376393-38-3 5'-O-tert-butyldimethylsilyl-(E)-5-(2-bromovinyl)-2'-deoxyuridine 
• 69304-47-8 (E)-5-(2-bromovinyl)-2'-deoxyuridine 

Downstream Products

• 345233-97-8 cyclo(3-methylsaligenyl)-5'-O-((E)-5-(2-bromovinyl)-2'-deoxy-3'-O-L-phenylalanyluridinyl)phosphate 
• 80860-82-8 (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-monophosphate 

Relevant academic research and scientific papers

CycloSal-BVDUMP pronucleotides: How to convert an antiviral-inactive nucleoside analogue into a bioactive compound against EBV

Novel cycloSal-BVDUMP triesters 2-4 5-[(E)-2-bromovinyl]-2′-deoxyuridine (BVDU, 1) have been studied with regard to their potential anti-EBV activity. In addition to the 3′-unmodified cycloSal-BVDUMP triesters 2a-f, the 3′-hydroxyl function has been ester

Synthesis, hydrolysis and anti-EBV activity of a series of 3′-modified cycloSal-BVDUMP pronucleotides

A series of cycloSal-BVDUMP phosphate triesters has been prepared. The prototype compound was 3-methyl-cycloSal-BVDUMP 2. Furthermore, a series of 3′-O-acyl-modified derivatives having carboxylic acids with different lipophilicity or a L-configurated α-am